{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-193295","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.342269+00:00","generated_at":"2026-06-13T03:18:39.463970+00:00","sec_items":["3.03","5.03","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Benitec Biopharma effects 1-for-17 reverse stock split to meet Nasdaq minimum bid price","bullets":["Reverse stock split of common stock at 1-for-17 ratio effective July 26, 2023 at 12:01 a.m. ET.","Intended to bring company into compliance with Nasdaq $1.00 minimum bid price requirement for continued listing.","No fractional shares issued; all fractional shares rounded up to nearest whole share.","CUSIP changes to 08205P209; trading symbol BNTC remains unchanged.","Stockholders need not take action; Computershare acts as exchange agent for the split."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-193295","json":"https://secwatch.observer/filing/0001193125-23-193295.json","markdown":"https://secwatch.observer/filing/0001193125-23-193295.md","text":"https://secwatch.observer/filing/0001193125-23-193295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/0001193125-23-193295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/d512923d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:18:39.463970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e18adad1c5078de9197bc3050586042e3e97b38","claim":"Benitec Biopharma Inc.: Certificate of Amendment to the Amended and Restated Certificate of Incorporation to effect a 1-for-17 reverse stock split (effective 2023-07-26).","evidence_excerpt":"On July 25, 2023, Benitec Biopharma Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which will effect, at 12:01 a.m. Eastern Time, on July 26, 2023 (the “Effective Time”), a 1-for-17 reverse stock split (the “Reverse Stock Split”)","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/0001193125-23-193295-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-07-26"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}